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Self-organized nanostructure modified microelectrode for sensitive
electrochemical glutamate detection in stem cells-derived brain organoids
Abstract

Neurons release neurotransmitters such as glutamate to communicate with each other and to coordinate brain
functioning. As increased glutamate release is indicative of neuronal maturation and activity, a system that can
measure glutamate levels over time within the same tissue and/or culture system is highly advantageous for
neurodevelopmental investigation. To address such challenges, we develop for the first time a convenient
method to realize functionalized borosilicate glass capillaries with nanostructured texture as an
electrochemical biosensor to detect glutamate release from cerebral organoids generated from human
embryonic stem cells (hESC) that mimic various brain regions. The biosensor shows a clear catalytic activity
toward the oxidation of glutamate with a sensitivity of 93 ± 9.5 nA·μM-1 ·cm-2 . It was found that the enzymemodified microelectrodes can detect glutamate in a wide linear range from 5 μM to 0.5 mM with a limit of
detection (LOD) down to 5.6 ± 0.2 μM. Measurements were performed within the organoids at different time
points and consistent results were obtained. This data demonstrates the reliability of the biosensor as well as
its usefulness in measuring glutamate levels across time within the same culture system.
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Abstract: Neurons release neurotransmitters such as glutamate to communicate with each other and
to coordinate brain functioning. As increased glutamate release is indicative of neuronal maturation
and activity, a system that can measure glutamate levels over time within the same tissue and/or
culture system is highly advantageous for neurodevelopmental investigation. To address such
challenges, we develop for the first time a convenient method to realize functionalized borosilicate
glass capillaries with nanostructured texture as an electrochemical biosensor to detect glutamate
release from cerebral organoids generated from human embryonic stem cells (hESC) that mimic
various brain regions. The biosensor shows a clear catalytic activity toward the oxidation of glutamate
with a sensitivity of 93 ± 9.5 nA·µM−1 ·cm−2 . It was found that the enzyme-modified microelectrodes
can detect glutamate in a wide linear range from 5 µM to 0.5 mM with a limit of detection (LOD)
down to 5.6 ± 0.2 µM. Measurements were performed within the organoids at different time points
and consistent results were obtained. This data demonstrates the reliability of the biosensor as well
as its usefulness in measuring glutamate levels across time within the same culture system.
Keywords: microelectrodes; electrochemical biosensors; amperometry; glutamate; human embryonic
stem cells; organoids
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1. Introduction
Glutamate is the principal excitatory neurotransmitter in the brain. In addition to its neuronal
signaling role, glutamate also plays critical roles in cortical development, including migration and
differentiation of cortical neurons. In contrast, high levels of glutamate may cause excitotoxicity and
neuronal death that are associated with multiple neuronal diseases, such as ischemia [1,2], Parkinson’s
disease [3,4], Alzheimer’s disease [5,6], and epilepsy [7–9].
These important roles of glutamate have generated a strong interest in the development of
devices for the detection and monitoring of this amino acid. Moreover, given its fundamental role in
corticogenesis and brain functioning, it would be valuable to measure glutamate levels at different
stages of human brain development and within brain regions, with relevance to neurodevelopmental
disorders. Neurospheres and cerebral organoids derived from human pluripotent stem cells (hPSC)
consist of a heterogeneous mix of differentiating neural and glia cell types and can therefore mimic
many of the dynamic processes occurring during brain development. This includes proliferation
of neuroepithelial cells, neural/glial differentiation and cortical patterning. Using small molecule
agonists and growth factors, neuronal cell fate within hPSC-derived neurospheres/organoids may
also be biased to model different brain regions. hPSC-derived organoids can also be generated from
patients suffering from neurodevelopmental or neurodegenerative conditions as potential disease
models. Therefore, the development of a system that allows multiple and continuous measurements of
glutamate levels within the same hPSC organoids cultured over time would greatly facilitate growing
organoids with regional and disease specific characteristics.
Different methods have been established to determine glutamate levels, including optical
methods [10,11], patch clamp [12], and microdialysis [13], as well as fluorometric [14],
chromatographic [15], or spectrophotometric techniques [16,17]. Many of these techniques have
intrinsic limitations, such as being time-consuming, requiring pre-treatment of the sample, being
labour intensive, and requiring skilled handling. In contrast, electrochemical methods are considered
as one of the most promising approaches because of low cost, simplicity, high sensitivity and specificity,
which is ideal for point-of care, implantable and portable devices [18–20]. Amongst neurochemical
devices, a range of amperometric biosensors have been developed based on loaded glutamate oxidase
enzyme [21–23].
Here, we report the development and characterization of an enzyme based “micropipette-like”
electrode with nanotextured probe, which is suitable for application in measuring glutamate levels
within human embryonic stem cells (hESCs) derived organoids. We chose to test our microelectrode
in a 3D organoid model in recognition of two-dimensional cell culture systems not being able to
recapitulate the complexity of brain architecture and functioning. By creating nanostructures on the
probe surface area we increased the binding capacity for the functional molecules to contribute in
reactions at the surface, thus facilitating the acquisition and transportation of signals and improving
sensitivity [24–28]. The performance of our nanotextured electrode was examined in hESC-derived
organoids consisting of different neuronal populations that are representative of different brain regions
and therefore likely differ in their glutamate levels. Measurements of glutamate levels were performed
within the same organoids and across different timepoints in culture, thereby showing the multi-use
application of the biosensor in live cell cultures. Overall, these studies demonstrate a novel approach
for measuring dynamic changes of neurrotransmitter levels within hESC-derived cerebral organoids,
a necessity for developing improved neurodevelopmental and neurological disorder models.
2. Materials and Methods
2.1. Materials
Dopamine (DA), ascorbic acid (AA), cysteine (Cus), uric acid (UA), serotonin, glucose,
dihydroxyphenylacetic acid (DOPAC), alanine (Ala); arginine (Arg); asparagine (Asn); aspartic
acid (Asp); glycine (Gly); histidine (His); trans-4-hydroxyl-L-proline (Hyp); isoleucine (Ile); leucine
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(Leu); lysine (Lys) and phosphate-buffered saline solution (PBS) all purchased from Sigma–Aldrich.
Fluor®Fluor
488 ®anti-rabbit-IgG
antibody,
DMEM/F12
medium,
rabbit
anti-v-Glut
Alexa
488 anti-rabbit-IgG
antibody,
DMEM/F12
medium,
rabbit
anti-v-Glutantibody
antibody (Abcam,
(Abcam,
Melbourne,
Australia),
mouse
anti-GAD67
(EMD
Millipore,
Bayswater,
Australia)
and
goat
Melbourne, Australia), mouse anti-GAD67 (EMD Millipore, Bayswater, Australia) and goat anti-rabbit
anti-rabbit
(555 nm) from
purchased
fromprobes,
Molecular
Life Technology.
(555
nm) purchased
Molecular
Lifeprobes,
Technology.
2.2. Apparatus
Self-organized nanostructures were formed by means of reactive ion etching (Oxford Plasma
Plasma
Lab100, Oxford instruments, Abingdon, UK). Metallization was performed via electron beam
evaporation (Intlvac Nanochrome, Fort Collins, CO, USA).
USA). The
The glass
glass micro-needles
micro-needles were prepared
through
micropipette
pullerpuller
(P-100 (P-100
Sutter Instrument,
Novato, CA,
USA). The
through a aflaming
flaming
micropipette
Sutter Instrument,
Novato,
CA,amperometric
USA). The
experiments
were
computer were
controlled
with data
acquisition
realized that
using
a CHI760
interface,
amperometric
experiments
computer
controlled
with that
datawas
acquisition
was
realized
using a
aCHI760
low-noise
damping
potentiostat
(600 E,potentiostat
CH Instruments,
TX, USA). Surface
of
interface,
a low-noise
damping
(600 E,Austin,
CH Instruments,
Austin, analysis
TX, USA).
fabricated
microelectrodes
was carried
out using scanning
helium
ionusing
microscopy
(Nanofab
Orion,
Surface analysis
of fabricated
microelectrodes
was carried
out
scanning
helium
ion
Zeiss,
Peabody,
MA, USA).
images
captured
usingimages
a confocal
microscope
(Leicaa
microscopy
(Nanofab
Orion,Fluorescence
Zeiss, Peabody,
MA,were
USA).
Fluorescence
were
captured using
SP8,
Wetzlar,
Germany)
withSP8,
Leica
Application
Suite with
X software.
confocal
microscope
(Leica
Wetzlar,
Germany)
Leica Application Suite X software.
2.3.
Biosensor Design
2.3. Biosensor
Design and
and Fabrication
Fabrication
Figure
a schematic
illustration
of the biosensor
fabricationfabrication
process. Theprocess.
glass micro-needles
Figure 1 1shows
shows
a schematic
illustration
of the biosensor
The glass
were
preparedwere
by pulling
borosilicate
capillaries
(i.d.
1.16 mm,
751.16
mmmm,
long,
scientific)
micro-needles
prepared
by pullingglass
borosilicate
glass
capillaries
(i.d.
75 SDR
mm long,
SDR
through
a
flaming
micropipette
puller
as
shown
in
Figure
1a.
The
micropipettes
with
suitable
geometry
scientific) through a flaming micropipette puller as shown in Figure 1a. The micropipettes with
(smoothly
tapered with
tip size
of 10 µm)
fabricated
by adjusting
the pulling
program.the
The
glass
suitable geometry
(smoothly
tapered
withwere
tip size
of 10 µm)
were fabricated
by adjusting
pulling
surfaces
were
cleaned
with
acetone,
2-propanol,
deionized
water
and
loaded
into
a
reactive
ion
etcher
program. The glass surfaces were cleaned with acetone, 2-propanol, deionized water and loaded
(RIE)
develop
under pseudo
Bosch processunder
[29]. The
RIE
into achamber
reactive to
ion
etcher self-organized
(RIE) chambernanostructures
to develop self-organized
nanostructures
pseudo
was
carried
out[29].
for 20
min
RF/ICP
powers
of20
600min
W/30
W andpowers
etchingof
gas
(SF
O2 :
6 : 100
Bosch
process
The
RIEatwas
carried
out for
at RF/ICP
600
W/30
Wsccm
and and
etching
10
sccm)
while
the
chamber
pressure
stabilized
at
20
torr.
gas (SF6: 100 sccm and O2: 10 sccm) while the chamber pressure stabilized at 20 torr.

Figure 1. Biofabrication: (a) Top left: An optical image of a bare micropipette, used as the platform
Figure 1. Biofabrication: (a) Top left: An optical image of a bare micropipette, used as the platform
for
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A helium ion microscope (HIM) equipped with charge cancellation system was used to observe
and inspect the probe surface area of the microelectrode. The HIM was armed with a very low
voltage electron gun (flood gun) to compensate for positive surface charge accumulation on the bare
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glutaraldehyde, which was mixed with 5 µL GluOx (50 U/mL). The exposed surface area was then
drop coated repetitively (10 times with one-minute interval) with microdrops (~1 µL) of enzyme
mixture using Eppendorf micropipette while the microelectrode turned over every time before drop
casting to ensure a uniform coating. (Figure 1c). After the coating procedure, sensors were cured at
least 24 h at 4 ◦ C prior to use. A very thin yellow transparent layer could be seen under a microscope.
2.5. Cell Culture
This project was approved by the University of Melbourne Human Ethics Committee (#1545384).
The hESC (WA-09, WiCell, Madison, SD, USA) cell line was cultured feeder free on vitronectin-coated
plates using MTeSR-1 defined media according to the manufacturer’s instructions (Stem Cell
Technologies, Tullamarine, Australia) and maintained at 37 ◦ C and 5% CO2 . Colonies were
mechanically dissected every 7 days and transferred to freshly coated plates. Cell culture medium
was changed every day. Neural induction and organoid formation of hESC were set up as described
by Denham and Dottori, with some minor modifications [31]. HESC colonies were mechanically
dissected into pieces approximately 0.5 mm in width and transferred to laminin-coated organ culture
plates in ‘N2B27’ medium containing 1:1 mix of DMEM/F12 medium and neural basal media (Life
Technologies/Invitrogen, Carlsbad, NM, USA) supplemented with 1% insulin/transferrin/selenium
(Life Technologies/Invitrogen), 1% N2 supplement (Life Technologies/Invitrogen), 1% retinol-free
B27 supplement (Life Technologies/Invitrogen), 0.3% glucose, 25 U/mL penicillin, and 25 µg/mL
streptomycin (Life Technologies/Invitrogen). For differentiation to dorsal forebrain neurons, N2B27
defined medium was supplemented with the small molecules SB431542 (10 uM, Tocris, Bristol, UK) and
LDN193189 (100 nM, KareBay Biochem, Monmouth Junction, NJ, USA) for 7 days. For differentiation
to ventral forebrain neurons, N2B27 was supplemented with small molecules SB431542 (10 µM),
LDN193189 (100 nM), and Smoothen Agonist (SAG; 400 nM, Merck Millipore, Bayswater, Australia)
for 7 days. Following initial neural induction, colonies from dorsal or ventral forebrain neural
inductions were treated with N2B27 medium supplemented with basic-fibroblast growth factor
(bFGF; 20 ng/mL, Peprotech, Rehovot, Israel) for a further 7 days. Following 2 weeks of neural
induction, neural progenitors were mechanically harvested and cultured in suspension in neural
basal media supplemented with 1% insulin/transferrin/selenium, 1% N2 supplement, 1% retinol-free
B27 supplement, 0.3% glucose, 25 U/mL penicillin, and 25 µg/mL streptomycin, bFGF, (20 ng/mL)
and epidermal growth factor (EGF; 20 ng/mL, Peprotech, Rehovot, Israel) to promote organoid
formation [32].
2.6. Immunoassay Analysis
Organoids were fixed with 4% paraformaldehyde and embedded in OCT for cryosectioning.
Frozen cryosections were immunostained using rabbit anti-vGlut antibody or mouse anti-GAD67
followed by goat anti-rabbit (555 nm) or goat anti-mouse (488 nm) Alexafluor secondary antibodies,
respectively. All samples were counterstained with 4’,6-diamidino-2-phenylindole (DAPI; 1 µg/mL,
Sigma-Aldrich, Castle Hill, Australia).
2.7. HPLC Analysis
Glutamate analysis was performed using the isocratic HPLC method which utilized
naphthalene-2,3-dicarboxylaldehyde (NDA, Sigma-Aldrich, Castle Hill, Australia) derivatisation
and subsequent fluorescence detection [33–35]. ESC-derived organoids were lysed by sonication
(50% Amplitude, 3 pulses at 5 s with 25 s intervals) in 2% EDTA, 0.1 M Acetic Acid buffer and
then centrifuged at 10,000 rpm for 5 min at room temperature. Supernatant was collected for HPLC
analyses. Fifty µL of either standard solution or sample was added to 450 µL of borate buffer (0.1 M,
pH 9.5), 100 µL of KCN (10 mM) and 100 µL of naphthalene-2,3-dicarboxylaldehyde (NDA, 6 mM) in
a reaction tube, and the derivatization reaction allowed to proceed for 20 min in the absence of light.
The fluorescent glutamate derivative (25 µL) was injected into the HPLC system, which consisted of
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a Waters 510 pump, a Bio-Rad AS-100 refrigerated auto sampler and an LDC FluoroMonitor 4100
programmable fluorescence detector at 420 nm excitation and 480 nm emission. The column was a
15 cm × 3.9 mm Waters Novapak C18 column, and the mobile phase was 20% acetonitrile in 50 mM
KH2 PO4 (pH 5.6) running at 2 mL/min. The method has within-day and between-day coefficients of
variation of 1.97% and 2.94%, respectively, at 1 µM.
3. Results and Discussion
3.1. Principle of the Amperometric Glutamate Biosensor
Nanostructured surfaces have excellent prospects for interfacing biological recognition events
with electronic signal transduction where active enzymes sites are coupled directly with the
nanostructure-based microelectrode resulting in direct electron transfer between the enzyme and
signal transducer and thus enhanced biosensing properties. The nanostructured microelectrode
provides an electro-active surface for enzyme immobilization with enhanced confirmation, orientation
and biological activity.
Electrochemical detection involving the use of an oxidoreductase, i.e., GluOx, typically occurs
according to the mechanism depicted in Figure S1. GluOx is one of the key elements when fabricating
glutamate sensors for improving selectivity, stability and sensitivity towards glutamate. Glutamate
oxidase (~140 kDa) has high substrate specificity to glutamate (kcat = 75 s−1 and Km = 0.23 mM) and
high stability (thermal stability ~80 ◦ C) [36,37]. It converts the substrate, glutamate, in presence of
oxygen and water into α-ketoglutarate, hydrogen peroxide and ammonia. The hydrogen peroxide
produced can be easily detected amperometrically [23]. Following the enzymatic reaction as described
below, conversion of 1 M of glutamate will ideally generate 1 M of H2 O2 .
L -glutamic

GluOx

acid + H2 O + O2 → α − ketoglutarate + NH3 + H2 O2

The hydrogen peroxide then reacts electrochemically on the Pt electrode as shown below:
H2 O2 → 2H+ + O2 + 2e−
For an ideal immobilization, the GluOx needs to bind to the electrode firmly and maintain its
structure and function properly after immobilization. The most common method for fabricating
glutamate biosensors is crosslinking which uses reagent bovine serum albumin (BSA) as the enzyme
stabilizer and glutaraldehyde as the crosslinker [21]. BSA is often included in the cross-linked matrix
to protect enzyme activity by creating a 3D network for enzyme attachment [1,38]. On the other hand,
glutaraldehyde is reactive towards the amine groups of lysine residues located mainly on protein
surfaces and therefore can crosslink and immobilize GluOx and BSA on the microelectrode surface.
Since other biogenic substances can also be oxidized at the microelectrode probe surface,
it was shielded with a permselective membrane to prevent these substances from approaching
the signal transducer (platinum layer) [39]. Therefore, prior to surface functionalization, PPD was
electropolymerized on the tip of the microelectrode using an amperometric process. The enzymatic
layer was then formed by drop-casting a solution comprising BSA, glutaraldehyde and GluOx.
The enzymatic layer, GluOx, was immobilized by drop-casting of 10 µL of an enzyme solution
containing 10% BSA and 0.125% glutaraldehyde mixed with 0.5 µL GluOx (1 U/µL) on the tip of a
borosilicate glass capillary at room temperature and then drying naturally for ~20 min.
3.2. Glutamate Biosensor Characterisation, Sensitivity and Selectivity Analysis
To address the analytical applicability of the Pt/PDD/GluOx coated microelectrodes we
investigated the electrocatalytic activity of these microelectrodes by measuring the current response
at different glutamate concentrations in PBS. Amperometry experiments were conducted using a
standard three-electrode set-up with Ag/AgCl as the reference and a platinum wire as the counter
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electrode. These experiments were computer controlled with data acquisition that was realized
using a CHI760 interface, a low-noise damping potentiostat. The biosensors were initially calibrated
as shown in Figure S2a. As described in other publications, electrochemical oxidation of H2 O2 is
achieved above +0.2 V [40–42]. Therefore, the chronoamperometric responses of the microelectrode
were recorded during the successive addition of 5.0 µM and 100 µM glutamate in 1 M PBS at an
applied potential of +0.7 V vs. Ag/AgCl which is optimal for H2 O2 detection [40]. It was observed
that the microelectrode could catalytically detect generated H2 O2 through electrochemical transducer.
To quantify the amperometric response, a calibration curve for each biosensor was created linking
the current response to the glutamate concentration (Figure S2b). It was found that the biosensors
responded linearly (R2 = 0.968 ± 0.007) to glutamate over the concentration range between 5 µM and
0.5 mM, with a LOD (3× standard measurement error bar of the baseline). Glutamine, of 5.6 ± 0.2 µM.
indicating suitability for detection of low glutamate levels in many biological applications. Using the
linear response range, the sensitivity was determined to be 93 ± 9.5 nA·µM−1 ·cm−2 by the slope of the
calibration curve for the glutamate biosensor. This is higher than a large number of reported glutamate
oxidase based sensors where the sensitivity varies between 2.15 and 65 nA·µM−1 ·cm−2 [43,44]. This
can be attributed to the high surface area of the nanostructure-based microelectrode.
Major challenges for enzymatic glutamate detection methods are electrochemically active
interferents, which generate electrochemical signals at the same potential as glutamate. Therefore the
biosensors were evaluated for interference at an applied potential of 0.7 V vs. the Ag/AgCl in 1 M PBS
solution with continuous additions of 100 µM aliquots of dopamine (DA), ascorbic acid (AA), cysteine
(Cus), uric acid (UA), serotonin, glucose, dihydroxyphenylacetic acid (DOPAC), alanine (Ala), arginine
(Arg), asparagine (Asn), aspartic acid (Asp), glycine (Gly), histidine (His), trans-4-hydroxyl-L-proline
(Hyp), isoleucine (Ile), leucine (Leu), lysine (Lys) and glutamate (Glut). It can be observed from the
current response in Figure S2c, that only a significant signal was obtained for glutamate compared to
the other amino acids. This implies that the Glu:H2 O2 ratio i.e., the effectiveness of enzyme GluOx to
convert glutamate to H2 O2 , was not affected by the presence of these potentially interfering substances.
3.3. Measurement of Glutamate within hESC-Derived Organoids
We and others have established protocols for generating organoids from hESC that consist of
cortical dorsal and ventral neural progenitors, which give rise to glutamatergic and GABAergic
neurons, respectively [45–47]. Figure S3 shows glutamatergic and GABAergic neurons by means
of an immunostaining method using rabbit anti-vGlut antibody or mouse anti-GAD67 followed by
goat anti-rabbit (555 nm) or goat anti-mouse (488 nm) Alexafluor secondary antibodies. Since dorsal
and ventral hESC-derived organoids mimic different brain regions with different cell populations,
there may also be differences in glutamate levels. To examine this hypothesis, an experimental setup
was designed for glutamate measurement inside organoids based on a microelectrode biosensor, Leica
M80 stereomicroscope with ESD design and Leica MATS heating system. In this apparatus, shown in
Figure 3a, the amperometric measurements were carried out in a sterile biohazard fume hood under an
upright zoom lens optical microscope. The microelectrode was mounted at an angle of 30–40 degrees
from the petri dish and directed into the field of view of the microscope. Then, it was lowered
gently and moved toward an organoid using a micromanipulator (SÜSS MicroTec AG, Garching,
Germany). The microelectrode was then slid sideways until it pierced an organoid from the side as
seen in Figure 3b and Figure S5. A potential of +0.7 V vs. Ag/AgCl was applied to the electrode to
record chronoamperograms. The microelectrode stayed still for about 100 s to allow recording signals
in response to glutamate concentration in the organoid before it was retracted. Three independent
biosensor readings were taken for each organoid in at least 20 dorsal forebrain organoids and 20
ventral forebrain organoids.
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of ease of use and low cost. This study provides compelling evidence for the utility of biosensors in
developing modelling of human brain function using stem cells.
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